Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 28 Feb 2018.
- 23 Nov 2017 Planned End Date changed from 6 Oct 2017 to 1 Dec 2017.
- 01 Sep 2017 Planned End Date changed from 1 Jun 2017 to 6 Oct 2017.